Tibotec, Virco
Founded Year
1994Stage
Acquired | AcquiredTotal Raised
$72.14MAbout Tibotec, Virco
Developer of new drugs, innovative treatment solutions and practical disease management tools for HIVAIDS and hepatitis C. The company is focusing on the discovery and development of HIV/AIDS compounds that are active against both wild-type HIV and strains of HIV that have developed drug resistance. HIV drug resistance is a major cause of treatment failure.
Missing: Tibotec, Virco's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Tibotec, Virco's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Tibotec, Virco Patents
Tibotec, Virco has filed 2 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/9/2007 | 7/12/2011 | Molecular biology, Animal virology, Virology, Animal viral diseases, Gene expression | Grant |
Application Date | 3/9/2007 |
|---|---|
Grant Date | 7/12/2011 |
Title | |
Related Topics | Molecular biology, Animal virology, Virology, Animal viral diseases, Gene expression |
Status | Grant |
Tibotec, Virco Frequently Asked Questions (FAQ)
When was Tibotec, Virco founded?
Tibotec, Virco was founded in 1994.
Where is Tibotec, Virco's headquarters?
Tibotec, Virco's headquarters is located at Mechelen Noord, Zone L,, Mechelen.
What is Tibotec, Virco's latest funding round?
Tibotec, Virco's latest funding round is Acquired.
How much did Tibotec, Virco raise?
Tibotec, Virco raised a total of $72.14M.
Who are the investors of Tibotec, Virco?
Investors of Tibotec, Virco include TrustCapital Partners, Sofinim, VIV NV and Ibel.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.